Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A-Reference-Cited by-同舟云学术

Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with haemophilia A

Published:2009-05 Issue:3 Volume:15 Page:718-726
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

VALENTINO L. A.,RECHT M.,DIPAOLA J.,SHAPIRO A. D.,PIPE S. W.,EWING N.,URGO J.,BULLOCK T.,SIMMONS M.,DEGUZMAN C.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01960.x/fullpdf

Reference38 articles.

1. 1 Kasper CK . Diagnosis and management of inhibitors to factors VIII and IX. An introductory discussion for physicians. Treatment of Hemophilia. World Federation of Hemophilia: September 2004: no. 34.

2. Immune Tolerance: High-Dose Regimen

3. Factor VIII inhibitors in mild and moderate-severity haemophilia A;Hay;Haemophilia,1998

4. Haemophilia A: mutation type determines risk of inhibitor formation;Schwaab;Thromb Haemost,1995

5. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A;Astermark;Blood,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Results of the Prospective ADVATE® Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII;Journal of Blood Medicine;2021-11

2. An update of the current pharmacotherapeutic armamentarium for hemophilia A;Expert Opinion on Pharmacotherapy;2021-08-18

3. Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry;Haemophilia;2019-10-11

4. Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child;Blood Coagulation & Fibrinolysis;2018-07

5. Current view and outcome of ITI therapy - A change over time?;Thrombosis Research;2016-12